Skip to main content

Pfizer Halts Drug Research For Alzheimer’s and Parkinson’s Because It’s Too Expensive [Updated]

By January 12, 2018News
pfizer-logo

pfizer-logo

Pfizer, one of the world’s largest drug companies, announced over the weekend that it would stop work on new drugs to fight Alzheimer’s disease and Parkinson’s disease. The reason? Pfizer believes that research on the two diseases doesn’t make sense financially.

{iframe}https://gizmodo.com/pfizer-halts-drug-research-for-alzheimers-and-parkinson-1821874256{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.